[Effect of dureping injection on T-cells function and their function in killing FM1 infected Mphi in vitro]

Shan Jing1, Li-gang Gu, Yun Zhou

  • 1Key Laboratory of Antivirus of the Ministry of Education, Beijing University of Chinese Medicine, Beijing.

Abstract

Insights

Dureping Injection (DRP) enhances T-cell immune response against influenza virus FM1 in mice. It boosts T-cell killing of infected cells while modulating cytokine production for better anti-viral immunity.

Area of Science:

  • Immunology
  • Virology
  • Pharmacology

Context:

  • Influenza virus subtype A (FM1) poses a significant threat to respiratory health.
  • T-cells play a crucial role in orchestrating adaptive immune responses against viral infections.
  • Understanding modulators of T-cell function is key to developing novel antiviral strategies.

Purpose:

  • To evaluate the impact of Dureping Injection (DRP) on murine T-cell function.
  • To assess DRP's effect on T-cell-mediated killing of influenza virus-infected cells in vitro.
  • To investigate DRP's influence on key cytokine production (IFN-γ and IL-10).

Summary:

  • DRP treatment modulated T-cell responses in vitro.
  • It inhibited normal T-cell proliferation induced by concanavalin A.
  • DRP suppressed Interleukin-10 (IL-10) production while maintaining Interferon-gamma (IFN-γ) levels, and significantly enhanced T-cell-mediated killing of FM1-infected macrophages.

Impact:

  • DRP demonstrates potential as an immunomodulatory agent for enhancing anti-influenza immunity.
  • The findings suggest DRP could bolster T-cell responses against influenza virus FM1.
  • Further research may explore DRP's therapeutic applications in managing influenza infections.

Related Concept Videos